Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the clinical events of the patients with acute
cerebral large vessel occlusion or stenosis and atrial fibrillation, treated by apixaban
within 14 days after onset. This is the observational study that patients will be made the
registration at the timing of both retrospective period and prospective period.